Mesoblast's IPO

Mesoblast raised a round of funding on November 13, 2015. Investors include Public.

Mesoblast is a biotechnology company committed to the development of novel treatments for orthopaedic conditions, including the commercialization of unique adult stem cells to regenerate and repair bo…

Articles about Mesoblast's IPO: